FOLD - Amicus Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue36,9304,958-1,224
Cost of Revenue6,236833--
Gross Profit30,6944,125-1,224
Operating Expenses
Research Development137,310101,29374,34345,224
Selling General and Administrative92,17174,65149,86923,117
Non Recurring----
Others----
Total Operating Expenses239,310180,019126,04569,888
Operating Income or Loss-202,380-175,061-126,045-68,664
Income from Continuing Operations
Total Other Income/Expenses Net-12,419-28,720-6,073-1,375
Earnings Before Interest and Taxes-202,380-175,061-126,045-68,664
Interest Expense-17,240-5,398-1,578-1,484
Income Before Tax-449,121-203,781-132,118-70,039
Income Tax Expense-165,119-3,739--1,113
Minority Interest----
Net Income From Continuing Ops-284,002-200,042-132,118-68,926
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-284,002-200,042-132,118-68,926
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-284,002-200,042-132,118-68,926